1 / 56

Zyprexa documents ppt 4.

Zyprexa documents ppt 4. This powerpoint has a selection of pages from documents to do with managing Adverse Drug Event issues. ZY100426128 US schizophrenia advisory panel review HGAJ study with advisor comments Dec1995. ZY100074131 FDA warning letter Nov 1996.

atira
Télécharger la présentation

Zyprexa documents ppt 4.

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Zyprexa documents ppt 4. This powerpoint has a selection of pages from documents to do with managing Adverse Drug Event issues.

  2. ZY100426128 US schizophrenia advisory panel review HGAJ study with advisor comments Dec1995

  3. ZY100074131 FDA warning letter Nov 1996

  4. ZY100074131 FDA warning letter Nov 1996

  5. ZY 100291752 European Agency for the Evaluation of Medicinal Products fax 1998

  6. ZY 100291752 European Agency for the Evaluation of Medicinal Products fax 1998

  7. ZY100291754 Lilly reply to Euro Agency for Medicines 1998

  8. ZY100363330 emails re German & Sth African hypergly/diabetes reports Mar1998

  9. ZY100363330 emails re diabetes Sep1999

  10. ZY100363361 Eli-Lilly review of spontaneous hypergly reports 1999

  11. ZY100363361 Eli-Lilly review of spontaneous hypergly reports 1999

  12. ZY100094522 internal Lilly email Dec1998 re hyperglycaemia and diabetes

  13. ZY100291761 review of hyperglycemia cases reported in Lilly database Sep96 -Jun98

  14. ZY100291761 review of hyperglycemia cases reported in Lilly database Sep96 -Jun98

  15. ZY100291761 review of hyperglycemia cases reported in Lilly database Sep96 -Jun98

  16. ZY100291761 review of hyperglycemia cases reported in Lilly database Sep96 -Jun98

  17. ZY100379985 ADEs report from early placebo controlled trials 1997or later (large font in document)

  18. ZY100382455 form letter for ?doctors re hypergly/diabetes aprox late 1999

  19. ZY201016928/9letter re high rate diabetes Nov1999

  20. ZY100363522 mtg minutes re in-house study re diabetes Aug 1999

  21. ZY100371941 Biological Psychiatry reviewers comments Nov 2000

  22. ZY100371941 Biological Psychiatry reviewers comments Nov 2000

  23. ZY100008867 Olz wght change int memo Dec1999

  24. ZY100008867 Olz wght change int memo Dec1999

  25. ZY100008867 Olz wght change int memo Dec1999

  26. ZY100008867 Olz wght change int memo Dec1999

  27. ZY100040198 verbatims for doctors re weight gain

  28. ZY100040198 verbatims for doctors re weight gain

  29. ZY100040198 verbatims for doctors re weight gain

  30. ZY100040198 verbatims for doctors re weight gain

  31. ZY100040198 verbatims for doctors re weight gain

  32. ZY100040198 verbatims for doctors re weight gain

  33. ZY100040198 verbatims for doctors re weight gain

  34. ZY100134405 Statement re diabetes, wght gain Oct 2000

  35. ZY100592565 Olanzapine core safety & efficacy beliefs summary undated. Notes EL trials not designed to spec test re diabetes

  36. ZY 100175585 Diabetes situation analysis Dec 2000

  37. ZY 100175585 Diabetes situation analysis Dec 2000

  38. ZY 100175585 Diabetes situation analysis Dec 2000

  39. ZY 100175585 Diabetes situation analysis Dec 2000

  40. ZY 100175585 Diabetes situation analysis Dec 2000

  41. ZY 100175585 Diabetes situation analysis Dec 2000

  42. ZY 100175585 Diabetes situation analysis Dec 2000

  43. ZY 100175630 Minutes of expert consultant mtg re diabetes and weight gain Aug 2000

  44. ZY 100175630 Minutes of expert mtg Aug 2000

  45. ZY 100175630 Minutes of expert mtg Aug 2000

  46. ZY 100175630 Minutes of expert mtg Aug 2000

  47. ZY100375967 Market research re doctors views diabetes and antipsychotics Sep 2000

  48. ZY100375967 Market research re doctors views diabetes and antipsychotics Sep 2000

  49. ZY100378053 email hyperglycaemia “threat for olanzapine” Sep 2000

  50. ZY100378054 emails re mtg with endocrinologic consultants Oct 2000

More Related